Skip to main navigation Skip to search Skip to main content

Superparamagnetic iron oxide nanoparticle-aptamer bioconjugates for combined prostate cancer imaging and therapy

  • Andrew Z. Wang
  • , Vaishali Bagalkot
  • , Christophoros C. Vasilliou
  • , Frank Gu
  • , Frank Alexis
  • , Liangfang Zhang
  • , Mariam Shaikh
  • , Kai Yuet
  • , Michael J. Cima
  • , Robert Langer
  • , Philip W. Kantoff
  • , Neil H. Bander
  • , Sangyong Jon*
  • , Omid C. Farokhzad
  • *Corresponding author for this work
  • Brigham and Women's Hospital
  • Massachusetts Institute of Technology
  • Gwangju Institute of Science and Technology
  • Massachusetts Institute of Technology
  • Harvard University
  • Cornell University

Research output: Contribution to journalArticlepeer-review

294 Scopus citations

Abstract

(Chemical Equation Presented) Multifunctional superparamagnetic iron oxide nanoparticles: Herein we report a novel, targeted, iron oxide nanoparticle for combined prostate cancer imaging and therapy. By conjugating an aptamer to a thermally stable iron oxide nanoparticle, we have demonstrated that bioconjugates can detect prostate cancer cells with high sensitivity and specificity. Furthermore, the bioconjugates can be used to deliver targeted chemotherapy.

Original languageEnglish
Pages (from-to)1311-1315
Number of pages5
JournalChemMedChem
Volume3
Issue number9
DOIs
StatePublished - 15 Sep 2008
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Doxorubicin
  • Nanoparticles
  • Superparamagnetic
  • TCL-SPION

Fingerprint

Dive into the research topics of 'Superparamagnetic iron oxide nanoparticle-aptamer bioconjugates for combined prostate cancer imaging and therapy'. Together they form a unique fingerprint.

Cite this